ask="N/A"
ask_size="N/A"
average_daily_volume="42992"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="+1.06"
change_from_200_day_moving_average="0.25"
change_from_50_day_moving_average="-1.47"
change_from_52_week_high="-6.84"
change_From_52_week_low="9.50"
change_in_percent="+5.74%"
close="19.52"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6898000"
high="19.60"
high_52_weeks="26.36"
last_trade_date="1/25/2017"
last_trade_price="19.52"
last_trade_size="688"
last_trade_time="4:00pm"
low="17.76"
low_52_weeks="10.02"
market_capitalization="326.26M"
moving_average_200_day="19.27"
moving_average_50_day="20.99"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="18.47"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.31%"
percent_change_from_50_day_moving_average="-7.00%"
percent_change_from_52_week_high="-25.95%"
percent_change_from_52_week_low="+94.81%"
previous_close="18.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.09"
stock_exchange="NGM"
symbol="PTGX"
volume="23733"
weeks_range_52="10.02 - 26.36"
